Journal profile · Pathology
Endocrine Pathology
ISSN 1046-3976 · eISSN 1559-0097 · Springer US · UNITED STATES · Quarterly · Founded 1990
Endocrine Pathology: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 4.6; hybrid open access; APC about USD 3,190; median 73 days to acceptance (48 articles, last 24 months); community-reported acceptance: fairly easy; 53 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Endocrine Pathology is published by Springer US and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Thyroid Cancer Diagnosis and Treatment, Neuroendocrine Tumor Research Advances and Pituitary Gland Disorders and Treatments, together about 38.7% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Endocrine Pathology publishes original articles on clinical and basic aspects of endocrine disorders. Work with animals or in vitro techniques is acceptable if it is relevant to human normal or abnormal endocrinology. Manuscripts will be considered for publication in the form of original articles, case reports, clinical case presentations, reviews, and descriptions of techniques. Submission of a paper implies that it reports unpublished work, except in abstract form, and is not being submitted simultaneously to another publication. Accepted manuscripts become the sole property of Endocrine Pathology and may not be published elsewhere without written consent from the publisher. All articles are subject to review by experienced referees. The Editors and Editorial Board judge manuscripts suitable for publication, and decisions by the Editors are final.
From the journal's Aims & Scope
Research area (LetPub): Pathology
Editor-in-chief Ozgur MetePublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 20, Italy 6, Australia 4, Germany 3, Japan 2 (51 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Thyroid Cancer Diagnosis and TreatmentMedicine14.5%
- Neuroendocrine Tumor Research AdvancesMedicine12.6%
- Pituitary Gland Disorders and TreatmentsMedicine11.6%
- Adrenal and Paraganglionic TumorsMedicine7.6%
- Neuroblastoma Research and TreatmentsMedicine7%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology4.6%
- Lung Cancer Research StudiesMedicine3.9%
- Growth Hormone and Insulin-like Growth FactorsMedicine3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Endocrinology & Metabolism | Zone 1 |
| Minor | Pathology | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
| Minor | Pathology | Zone 1 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pathology | Zone 1 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.6LetPub ·
- Impact factor (publisher) 2025
- 4.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 8.9Publisher website ·
- CiteScore 2026-06
- 22.3LetPub ·
- SJR 2026-06
- 3.72LetPub ·
- SNIP 2026-06
- 5.34LetPub ·
- h-index
- 42LetPub ·
- h-index
- 76OpenAlex ·
- i10-index
- 970OpenAlex ·
- 2-year mean citedness
- 5.45OpenAlex ·
- Self-citation rate
- 15.2%LetPub ·
- Share of gold OA articles
- 48.78%LetPub ·
Volume
- Articles per year
- 44LetPub ·
- Downloads per year (publisher) 2025
- 318,000Publisher website ·
Articles by year OpenAlex count · 1,706 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 38 | 24 | 23 |
| 2025 | 53 | 35 | 294 |
| 2024 | 49 | 25 | 446 |
| 2023 | 49 | 17 | 613 |
| 2022 | 46 | 22 | 4,473 |
| 2021 | 46 | 20 | 1,273 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
73 daysMedian, submission to acceptance · P25–P75 40 days – 114 days
- Acceptance to online
- median 13 days (84 articles)
- Submission to online
- median 87 days
- Sample
- 48 articles with submission and acceptance dates (110 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,190 / EUR 5,090 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Other fees
- No other fees
- Page charges
- No page charges
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted7, with length limits
- case reportThe following types of articles will be considered for publication: Original Article Basic Research and Clinical Research. Please include an unstructured abstra…main text ≤ 1,500 words · figures and tables ≤ 4
- correspondenceThe following types of articles will be considered for publication: Original Article Basic Research and Clinical Research. Please include an unstructured abstra…main text ≤ 1,000 words
- images in endocrine pathologyImages in Endocrine Pathology Submissions to this section illustrate examples of interesting endocrine pathology entities with clinical photographs, radiographi…Length not stated
- original articleThe following types of articles will be considered for publication: Original Article Basic Research and Clinical Research. Please include an unstructured abstra…main text ≤ 3,500 words · references ≤ 50
- research articleThe following types of articles will be considered for publication: Original Article Basic Research and Clinical Research. Please include an unstructured abstra…main text ≤ 3,500 words
- reviewThe following types of articles will be considered for publication: Original Article Basic Research and Clinical Research. Please include an unstructured abstra…main text ≤ 4,500 words
- review articleThe following types of articles will be considered for publication: Original Article Basic Research and Clinical Research. Please include an unstructured abstra…main text ≤ 4,500 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
COPE member Model summary
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Endocrine Pathology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1990
- ISSN
- 1046-3976
- Electronic ISSN
- 1559-0097
- Society / sponsor
- Endocrine Pathology Society) publishes research on clinical and basic aspects of endocrine disorders
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Endocrine Pathology
What CAS zone is Endocrine Pathology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Endocrine Pathology is in Zone 1 of Medicine, and in Zone 1 of the minor category Endocrinology & Metabolism / Pathology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Endocrine Pathology?
The latest impact factor listed by LetPub is 4.6; CiteScore 22.3, h-index 76.
How long does peer review take at Endocrine Pathology?
Based on the dates recorded on 48 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 73 days (interquartile range 40–114 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Endocrine Pathology?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Endocrine Pathology based?
Of the 51 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (20), Italy (6) and Australia (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Endocrine Pathology?
According to LetPub and DOAJ records, Endocrine Pathology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Endocrine Pathology open access, and what is the APC?
Endocrine Pathology is a hybrid journal. For open-access publication: APC about USD 3,190.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .